1. A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B‐cell lymphoma. (23rd August 2013) Authors: Coiffier, Bertrand; Radford, John; Bosly, André; Martinelli, Giovanni; Barca, Gabriela; Davies, Andrew; Decaudin, Didier; Gallop‐Evans, Eve; Padmanabhan‐Iyer, Swaminathan; Van, Koen; Wu, Ka Lung; Gupta, Ira V.; Lin, Thomas S.; Goldstein, Nancy; Jewell, Roxanne C.; Winter, Paul; Lisby, Steen Journal: British journal of haematology Issue: Volume 163:Number 3(2013:Nov.) Page Start: 334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers. Issue 4 (9th April 2023) Authors: Soefje, Scott A.; Carpenter, Corinne; Carlson, Katherine; Awasthi, Samir; Lin, Thomas S.; Kaila, Shuchita; Tarjan, Daniel; Kayal, Nikhil; Kirkup, Christian; Wagner, Tyler E.; Gray, Kathleen S.; Kumar, Shaji Journal: JCO oncology practice Issue: Volume 19:Issue 4(2023) Page Start: e542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study. (16th September 2022) Authors: Sborov, Douglas W.; Baljevic, Muhamed; Reeves, Brandi; Laubach, Jacob; Efebera, Yvonne A.; Rodriguez, Cesar; Costa, Luciano J.; Chari, Ajai; Silbermann, Rebecca; Holstein, Sarah A.; Anderson, Larry D.; Kaufman, Jonathan L.; Shah, Nina; Pei, Huiling; Patel, Sharmila; Cortoos, Annelore; Bartlett, J... Journal: British journal of haematology Issue: Volume 199:Number 3(2022) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. (3rd March 2019) Authors: Yimer, Habte; Melear, Jason; Faber, Edward; Bensinger, William I.; Burke, John M.; Narang, Mohit; Stevens, Don; Gunawardena, Sriya; Lutska, Yana; Qi, Keqin; Ukropec, Jon; Qi, Ming; Lin, Thomas S.; Rifkin, Robert M. Journal: British journal of haematology Issue: Volume 185:Number 3(2019) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for multiple myeloma: final results of the LYRA study. Issue 10 (24th August 2022) Authors: Yimer, Habte; Melear, Jason; Faber, Edward; Bensinger, William I.; Burke, John M.; Narang, Mohit; Stevens, Don; Gray, Kathleen S.; Lutska, Yana; Bobba, Padma; Qi, Keqin; Hoehn, Daniela; Qi, Ming; Lin, Thomas S.; Rifkin, Robert M. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 10(2022) Page Start: 2383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term follow-up of previously treated and treatment-naïve patients who received tositumomab and I-131 tositumomab. Issue 5 (3rd May 2016) Authors: Horner, Thierry J.; Williams, Vanessa C.; Giampietro, Patricia; Witman, Philip A.; Lin, Thomas S. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 5(2016:May) Page Start: 1238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101. Issue 12 (December 2013) Authors: Jones, Jeffrey A.; Ruppert, Amy S.; Zhao, Weiqiang; Lin, Thomas S.; Rai, Kanti; Peterson, Bercedis; Larson, Richard A.; Marcucci, Guido; Heerema, Nyla A.; Byrd, John C. Journal: Leukemia & lymphoma Issue: Volume 54:Issue 12(2013:Dec.) Page Start: 2654 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab. Issue 3 (March 2015) Authors: Quackenbush, Robert C.; Horner, Thierry J.; Williams, Vanessa C.; Giampietro, Patricia; Lin, Thomas S. Journal: Leukemia & lymphoma Issue: Volume 56:Issue 3(2015:Mar.) Page Start: 779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma. Issue 22 (5th November 2018) Authors: Chari, Ajai; Lonial, Sagar; Mark, Tomer M.; Krishnan, Amrita Y.; Stockerl‐Goldstein, Keith E.; Usmani, Saad Z.; Londhe, Anil; Etheredge, Delores; Fleming, Sarah; Liu, Baolian; Ukropec, Jon; Lin, Thomas S.; Jagannath, Sundar; Nooka, Ajay K. Journal: Cancer Issue: Volume 124:Issue 22(2018) Page Start: 4342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗